Application no. and date | 15857703.1 (espacenet) (Federated) (European Patent Register), 20151106 | Patent/reg. no. and date | DK/EP 3215193, 20231004 | Publication date | 20170913 | Priority no. and date | EP 14192114, 20141106 | EP pub. no. and date |
EP 3215193 20170913 | Effective date | | Applicant/owner | PharmaEssentia Corporation, 13F, No. 3 Park (YuanQu) Street Nangang District
Taipei City 11503, TW | Applicant ref. no. | P383161.DK.01/WOODJ/LJUNGBERGR | Inventor | LIN, Ko-Chung, 253 Lincoln Street
Lexington, MA 02421, US, KLADE, Christoph, Wilhelminenstrasse 91/lif
1160 Vienna, AT, ZAGRIJTSCHUK, Oleh, Wilhelminenstrasse 91/lif
1160 Vienna, AT | Representative | Murgitroyd & Company, Mannerheimvägen 12 B
5:e våningen
FI-00100 Helsingfors, FI | Opponent | | IPC Class | A61K 38/21 (2006.01) , A61K 47/60 (2017.01) , A61P 19/00 (2006.01) , A61P 19/04 (2006.01) , A61P 19/08 (2006.01) , A61P 31/00 (2006.01) , A61P 35/00 (2006.01) , A61P 35/02 (2006.01) , A61P 7/00 (2006.01) | Title | DOSERINGSREGIME FOR PEGYLERET INTERFERON | Int. application no. | US2015059410 | Int. publication no. | WO2016073825 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|